MedTrace Logo

Veinplicity for Improved Venous Access: The VIVA Trial

NCT03752632 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2019-10-30

No results posted yet for this study

Summary

This study will assess the safety and effectiveness of the Veinplicity device to improve the visualization and palpability of difficult-to-access veins for intravenous cannulation.

Conditions

  • Difficult-to-access Veins for Intravenous Cannulation

Interventions

DEVICE

Veinplicity with tourniquet

Veinplicity will be used with a tourniquet

DEVICE

Tourniquet

A tourniquet alone will be used.

Sponsors & Collaborators

  • Regulatory and Clinical Research Institute Inc

    collaborator OTHER

  • Physeon GmbH

    lead INDUSTRY

Principal Investigators

  • Gregory J Schears, MD · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-01
Primary Completion
2019-07-22
Completion
2019-07-22
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03752632 on ClinicalTrials.gov